US Stock MarketDetailed Quotes

Halozyme Therapeutics (HALO)

Watchlist
  • 64.490
  • -0.870-1.33%
Close Apr 27 16:00 ET
  • 64.490
  • 0.0000.00%
Pre 04:00 ET
7.64BMarket Cap25.19P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Halozyme Therapeutics (HALO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
37.55%1.4B
51.60%451.77M
22.12%354.26M
40.79%325.72M
35.22%264.86M
22.44%1.02B
29.55%298.01M
34.28%290.08M
4.67%231.35M
20.81%195.88M
Operating revenue
37.55%1.4B
51.60%451.77M
22.12%354.26M
40.79%325.72M
35.22%264.86M
22.44%1.02B
29.55%298.01M
34.28%290.08M
4.67%231.35M
20.81%195.88M
Cost of revenue
43.51%228.77M
87.30%78.77M
11.77%55.24M
17.05%46.36M
70.86%48.4M
-17.13%159.42M
-19.59%42.06M
-9.84%49.43M
-20.90%39.61M
-19.45%28.33M
Gross profit
36.44%1.17B
45.73%373M
24.25%299.02M
45.69%279.36M
29.19%216.46M
34.39%855.91M
44.00%255.95M
49.28%240.66M
12.15%191.75M
31.96%167.55M
Operating expense
19.98%365.24M
64.45%132.3M
4.70%81.1M
3.23%76.92M
4.05%74.92M
1.71%304.43M
4.88%80.45M
6.21%77.46M
-2.61%74.51M
-1.59%72.01M
Selling and administrative expenses
34.18%207.09M
82.32%77.03M
11.75%46.09M
16.53%41.61M
20.57%42.36M
3.45%154.34M
12.34%42.25M
16.93%41.24M
-8.31%35.71M
-5.95%35.13M
Research and development costs
3.09%81.49M
56.04%31.9M
-6.54%17.25M
-16.61%17.54M
-22.56%14.8M
3.52%79.05M
-4.19%20.44M
6.56%18.46M
6.65%21.04M
6.30%19.11M
Depreciation amortization depletion
7.90%76.66M
31.61%23.38M
0.00%17.76M
0.00%17.76M
-0.01%17.76M
-3.69%71.05M
0.00%17.76M
-12.68%17.76M
-0.41%17.76M
-0.40%17.76M
-Depreciation and amortization
7.90%76.66M
31.61%23.38M
0.00%17.76M
0.00%17.76M
-0.01%17.76M
-3.69%71.05M
0.00%17.76M
-12.68%17.76M
-0.41%17.76M
-0.40%17.76M
Operating profit
45.54%802.59M
37.15%240.7M
33.53%217.92M
72.68%202.44M
48.14%141.54M
63.36%551.48M
73.70%175.5M
84.87%163.2M
24.11%117.24M
77.58%95.54M
Net non-operating interest income expense
-0.17%-18.13M
-8.17%-4.91M
5.04%-4.3M
2.87%-4.39M
-0.40%-4.53M
3.56%-18.1M
13.03%-4.54M
-0.42%-4.52M
-0.67%-4.52M
0.79%-4.51M
Non-operating interest expense
0.17%18.13M
8.17%4.91M
-5.04%4.3M
-2.87%4.39M
0.40%4.53M
-3.56%18.1M
-13.03%4.54M
0.42%4.52M
0.67%4.52M
-0.79%4.51M
Other net income (expense)
-1,437.12%-317.59M
-4,741.31%-336.63M
-17.62%5.33M
36.94%6.89M
36.55%6.82M
-19.53%23.75M
35.32%7.25M
-64.01%6.47M
57.64%5.03M
67.61%4.99M
Gain on sale of security
-9.60%21.47M
-66.50%2.43M
-17.62%5.33M
36.94%6.89M
36.55%6.82M
45.57%23.75M
35.32%7.25M
35.27%6.47M
57.64%5.03M
67.61%4.99M
Special income (charges)
---339.06M
----
----
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
--284.89M
----
----
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--48.7M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--5.48M
----
----
----
----
----
----
----
----
----
Income before tax
-16.20%466.88M
-156.59%-100.85M
32.58%218.96M
74.06%204.94M
49.78%143.83M
59.94%557.13M
76.14%178.21M
62.29%165.15M
26.39%117.74M
83.83%96.03M
Income tax
32.68%149.99M
-1.12%40.74M
55.43%43.73M
62.37%39.78M
33.99%25.73M
69.39%113.04M
160.99%41.2M
41.22%28.14M
33.13%24.5M
52.14%19.21M
Net income
-28.64%316.89M
-203.34%-141.59M
27.89%175.23M
77.12%165.16M
53.72%118.1M
57.71%444.09M
60.46%137.01M
67.42%137.01M
24.74%93.25M
93.92%76.82M
Net income continuous Operations
-28.64%316.89M
-203.34%-141.59M
27.89%175.23M
77.12%165.16M
53.72%118.1M
57.71%444.09M
60.46%137.01M
67.42%137.01M
24.74%93.25M
93.92%76.82M
Minority interest income
Net income attributable to the parent company
-28.64%316.89M
-203.34%-141.59M
27.89%175.23M
77.12%165.16M
53.72%118.1M
57.71%444.09M
60.46%137.01M
67.42%137.01M
24.74%93.25M
93.92%76.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.64%316.89M
-203.34%-141.59M
27.89%175.23M
77.12%165.16M
53.72%118.1M
57.71%444.09M
60.46%137.01M
67.42%137.01M
24.74%93.25M
93.92%76.82M
Basic earnings per share
-24.57%2.64
-211.11%-1.2
37.96%1.49
86.30%1.36
57.38%0.96
64.32%3.5
66.15%1.08
74.19%1.08
28.07%0.73
110.34%0.61
Diluted earnings per share
-25.36%2.56
-213.21%-1.2
36.19%1.43
84.72%1.33
55.00%0.93
63.33%3.43
63.08%1.06
72.13%1.05
28.57%0.72
106.90%0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 37.55%1.4B51.60%451.77M22.12%354.26M40.79%325.72M35.22%264.86M22.44%1.02B29.55%298.01M34.28%290.08M4.67%231.35M20.81%195.88M
Operating revenue 37.55%1.4B51.60%451.77M22.12%354.26M40.79%325.72M35.22%264.86M22.44%1.02B29.55%298.01M34.28%290.08M4.67%231.35M20.81%195.88M
Cost of revenue 43.51%228.77M87.30%78.77M11.77%55.24M17.05%46.36M70.86%48.4M-17.13%159.42M-19.59%42.06M-9.84%49.43M-20.90%39.61M-19.45%28.33M
Gross profit 36.44%1.17B45.73%373M24.25%299.02M45.69%279.36M29.19%216.46M34.39%855.91M44.00%255.95M49.28%240.66M12.15%191.75M31.96%167.55M
Operating expense 19.98%365.24M64.45%132.3M4.70%81.1M3.23%76.92M4.05%74.92M1.71%304.43M4.88%80.45M6.21%77.46M-2.61%74.51M-1.59%72.01M
Selling and administrative expenses 34.18%207.09M82.32%77.03M11.75%46.09M16.53%41.61M20.57%42.36M3.45%154.34M12.34%42.25M16.93%41.24M-8.31%35.71M-5.95%35.13M
Research and development costs 3.09%81.49M56.04%31.9M-6.54%17.25M-16.61%17.54M-22.56%14.8M3.52%79.05M-4.19%20.44M6.56%18.46M6.65%21.04M6.30%19.11M
Depreciation amortization depletion 7.90%76.66M31.61%23.38M0.00%17.76M0.00%17.76M-0.01%17.76M-3.69%71.05M0.00%17.76M-12.68%17.76M-0.41%17.76M-0.40%17.76M
-Depreciation and amortization 7.90%76.66M31.61%23.38M0.00%17.76M0.00%17.76M-0.01%17.76M-3.69%71.05M0.00%17.76M-12.68%17.76M-0.41%17.76M-0.40%17.76M
Operating profit 45.54%802.59M37.15%240.7M33.53%217.92M72.68%202.44M48.14%141.54M63.36%551.48M73.70%175.5M84.87%163.2M24.11%117.24M77.58%95.54M
Net non-operating interest income expense -0.17%-18.13M-8.17%-4.91M5.04%-4.3M2.87%-4.39M-0.40%-4.53M3.56%-18.1M13.03%-4.54M-0.42%-4.52M-0.67%-4.52M0.79%-4.51M
Non-operating interest expense 0.17%18.13M8.17%4.91M-5.04%4.3M-2.87%4.39M0.40%4.53M-3.56%18.1M-13.03%4.54M0.42%4.52M0.67%4.52M-0.79%4.51M
Other net income (expense) -1,437.12%-317.59M-4,741.31%-336.63M-17.62%5.33M36.94%6.89M36.55%6.82M-19.53%23.75M35.32%7.25M-64.01%6.47M57.64%5.03M67.61%4.99M
Gain on sale of security -9.60%21.47M-66.50%2.43M-17.62%5.33M36.94%6.89M36.55%6.82M45.57%23.75M35.32%7.25M35.27%6.47M57.64%5.03M67.61%4.99M
Special income (charges) ---339.06M------------------0--0--0--------
-Less：Restructuring and merger&acquisition --284.89M------------------0--0--0--------
-Less:Impairment of capital assets --48.7M------------------0----------------
-Less:Other special charges --5.48M------------------------------------
Income before tax -16.20%466.88M-156.59%-100.85M32.58%218.96M74.06%204.94M49.78%143.83M59.94%557.13M76.14%178.21M62.29%165.15M26.39%117.74M83.83%96.03M
Income tax 32.68%149.99M-1.12%40.74M55.43%43.73M62.37%39.78M33.99%25.73M69.39%113.04M160.99%41.2M41.22%28.14M33.13%24.5M52.14%19.21M
Net income -28.64%316.89M-203.34%-141.59M27.89%175.23M77.12%165.16M53.72%118.1M57.71%444.09M60.46%137.01M67.42%137.01M24.74%93.25M93.92%76.82M
Net income continuous Operations -28.64%316.89M-203.34%-141.59M27.89%175.23M77.12%165.16M53.72%118.1M57.71%444.09M60.46%137.01M67.42%137.01M24.74%93.25M93.92%76.82M
Minority interest income
Net income attributable to the parent company -28.64%316.89M-203.34%-141.59M27.89%175.23M77.12%165.16M53.72%118.1M57.71%444.09M60.46%137.01M67.42%137.01M24.74%93.25M93.92%76.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.64%316.89M-203.34%-141.59M27.89%175.23M77.12%165.16M53.72%118.1M57.71%444.09M60.46%137.01M67.42%137.01M24.74%93.25M93.92%76.82M
Basic earnings per share -24.57%2.64-211.11%-1.237.96%1.4986.30%1.3657.38%0.9664.32%3.566.15%1.0874.19%1.0828.07%0.73110.34%0.61
Diluted earnings per share -25.36%2.56-213.21%-1.236.19%1.4384.72%1.3355.00%0.9363.33%3.4363.08%1.0672.13%1.0528.57%0.72106.90%0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -